1993
DOI: 10.1016/0738-081x(93)90059-l
|View full text |Cite
|
Sign up to set email alerts
|

The red face: Atopic dermatitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1999
1999
2014
2014

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 40 publications
0
3
0
Order By: Relevance
“…The reddened face of seborrhoeic dermatitis may also involve secondary conjunctivitis, but the estimated occurrence of this dermatosis in the general population is only 1-3% [20]. Atopic dermatitis can be another cause of a red face, thought to affect 20% of the population, and the hands are commonly involved [21]. The face is also a common site for contact or photocontact dermatitis to manifest itself.…”
Section: Introductionmentioning
confidence: 99%
“…The reddened face of seborrhoeic dermatitis may also involve secondary conjunctivitis, but the estimated occurrence of this dermatosis in the general population is only 1-3% [20]. Atopic dermatitis can be another cause of a red face, thought to affect 20% of the population, and the hands are commonly involved [21]. The face is also a common site for contact or photocontact dermatitis to manifest itself.…”
Section: Introductionmentioning
confidence: 99%
“…), especially in girls . During the adolescent or adult stage, facial symptoms are usually aggravated and patients can sometimes display what is called ‘atopic red face’ …”
Section: Recent Developmentsmentioning
confidence: 99%
“…Facial redness in dermatology has a broad spectrum of etiologies, including steroid dermatitis, rosacea, seborrheic dermatitis, and AD. 4,5 Because facial skin is thinner than skin in other areas, the repeated use of topical steroids on the face makes skin more susceptible to steroid-induced side effects such as atrophy, telangiectasia, perioral dermatitis, and rosacea. 6,7 Although topical tacrolimus or pimecrolimus have been reported to effectively control eczema and pruritus in patients with facial AD who are dependent on topical steroids, 8 its effect on the underlying distended vasculature is minimal.…”
mentioning
confidence: 99%